CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 279 filers reported holding CUBIST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $1,539,000 | -4.5% | 22,043 | 0.0% | 0.04% | -15.4% |
Q1 2014 | $1,612,000 | -13.3% | 22,043 | -18.4% | 0.05% | -10.3% |
Q4 2013 | $1,859,000 | +50.6% | 27,000 | +39.1% | 0.06% | +45.0% |
Q3 2013 | $1,234,000 | +276.2% | 19,417 | +186.1% | 0.04% | -54.5% |
Q2 2013 | $328,000 | – | 6,786 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AKANTHOS CAPITAL MANAGEMENT LLC | 50,500 | $3,526,000 | 10.49% |
Palo Alto Investors LP | 1,526,916 | $106,609,000 | 7.94% |
HealthCor Management, L.P. | 1,225,000 | $85,530,000 | 4.29% |
SECTOR GAMMA AS | 192,490 | $13,440,000 | 3.18% |
AMI ASSET MANAGEMENT CORP | 363,698 | $25,393,000 | 2.52% |
EAGLE BOSTON INVESTMENT MANAGEMENT INC | 578,207 | $40,370,000 | 2.01% |
TURNER INVESTMENTS LLC | 559,239 | $39,046,000 | 1.73% |
Tekla Capital Management LLC | 263,772 | $18,417,000 | 1.69% |
MAZAMA CAPITAL MANAGEMENT INC | 80,221 | $5,601,000 | 1.50% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 3,234,570 | $225,838,000 | 1.34% |